id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-N-1428-0011,FDA,FDA-2013-N-1428,"Electronic Drug Product Reporting for Human Drug Compounding Outsourcing Facilities Under Section 503B of the Federal Food, Drug, and Cosmetic Act Revised Draft Guidance",Other,Guidance,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,,2024-11-11T20:55:17Z,,1,0,0900006481941993
FDA-2013-N-1428-0010,FDA,FDA-2013-N-1428,Electronic Product Reporting for Human Drug Compounding Outsourcing Facilities; Draft Guidance,Notice,Notice of Availability,2014-11-24T05:00:00Z,2014,11,2014-11-24T05:00:00Z,2015-01-24T04:59:59Z,2019-07-17T12:23:03Z,2014-27691,0,0,09000064819413b6